logo
Gig Speeds for Every American? Trump FCC Moves to Drop One of the Group's Most Ambitious Goals

Gig Speeds for Every American? Trump FCC Moves to Drop One of the Group's Most Ambitious Goals

CNET4 days ago
One of the federal government's most ambitious broadband targets may soon be abandoned. On August 7, the FCC will vote on a proposal to drop its goal of gig speeds for every American.
In March last year, the Democratic-led group voted to raise the definition of minimum broadband speeds from 25Mbps download and 3Mbps upload speed to 100/20Mbps. It also set a more ambitious long-term goal of increasing the benchmark to 1,000Mbps download and 500Mbps upload speed.
Trump's pick for FCC chair, Brendan Carr, has consistently advocated for a 'technology neutral' approach to broadband subsidies. There's only one broadband technology that can currently reach 1,000/500Mbps, and that's fiber internet.
Carr's proposal repeatedly points to the previous, Democrat-led FCC's goals as outside the bounds of Section 706 of the Telecommunications Act of 1996, which requires the FCC to 'encourage the deployment' of telecommunications service 'on a reasonable and timely basis' to all Americans.
"Not only is a long-term goal not mentioned in section 706, but maintaining such a goal risks skewing the market by unnecessarily potentially picking technological winners and losers," Carr's plan says.
Locating local internet providers
While Carr was critical of the increase to the minimum broadband threshold when it passed last year, there is no mention of rolling back the 100/20Mbps requirement.
Changes in how we measure broadband progress
Another notable departure from the 2024 report is how the FCC could measure broadband deployment going forward. Last year, for example, the Commission determined that 7% of Americans did not have access to 100/20Mbps speeds. Carr's proposal argues that this is a flawed way to measure progress toward closing the digital divide.
It all hinges on one key sentence used in Section 706: 'The Commission shall determine whether advanced telecommunications capability is being deployed to all Americans in a reasonable and timely fashion.'
Carr's proposal argues that the FCC has been (wrongly) measuring where broadband has been deployed already, not where it is in the process of being deployed.
'We believe that the prior Report's binary interpretation of the threshold for issuing a passing or failing grade in the ultimate section 706 finding effectively read the 'reasonable and timely' language out of the statute,' Carr's proposal says. 'That interpretation seemingly found anything short of 100% was insufficient to warrant a passing grade and thus disregarded Congress's use of the present progressive tense in 'is being deployed.''
The interpretation of that phrase could have huge repercussions. Section 706 requires that if broadband is not being deployed to all Americans, the FCC must 'accelerate deployment of such capability by removing barriers to infrastructure investment and by promoting competition.'
With $42.5 billion in federal funding through the Broadband Equity Access and Deployment (BEAD) Program currently being deployed to states, the FCC can reasonably argue that broadband is in the process of being deployed to all Americans. If the question was whether all Americans have access to broadband speeds -- as the Democratic-led FCC previously interpreted -- the answer would be a resounding no, and the FCC would be required to take concrete action to achieve that goal.
Broadband affordability is no longer an FCC goal
It's easy to miss the affordability aspect in Carr's proposal, but it could have far-reaching impacts. It says that the previous FCC read 'several extraneous universal service criteria' into section 706. In a footnote to that sentence, it defines these criteria as 'deployment, adoption, affordability, availability and equitable access.'
In last year's report, the FCC determined that, 'The legislative history of section 706 further supports the view that Congress expects us to examine more than physical availability, and explicitly identifies affordability in describing the goals of section 706.'
Carr vehemently disagreed with this interpretation, writing in a dissenting statement, 'That cannot be right. For one, those terms appear nowhere in Section 706.'
Most broadband experts agree that cost is the main reason people don't have home internet, not a lack of availability. That was borne out when 23 million Americans enrolled in the Affordable Connectivity Program, a federal subsidy to help low-income families pay for internet that expired one year ago.
"As folks in this space like to say, if it's not affordable, it's not accessible," Sean Gonsalvez, a director of communication with the advocacy group The Institute for Local Self-Reliance, told me in a previous interview.
A 2021 Pew Research Center survey found that one in five people who don't have a broadband subscription cited cost as the main reason -- the highest of any answer and well above the number who said service isn't available. Another study found that "for every American without broadband service available, up to twice as many have service available but still don't subscribe."
Even though affordability was outlined as a goal in last year's report, the previous FCC did not make much progress on the issue. Instead, it's been largely left up to states to legislate.
In New York, for example, internet providers are required to offer low-income residents plans as low as $15 per month. In mid-December, the Supreme Court declined to hear a challenge to the law. One month later, AT&T announced it would be removing access to its AT&T Internet Air service in New York.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Yahoo

time20 minutes ago

  • Yahoo

Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT

Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

The Open Group Launches The Open Group Open Digital Transformation™ Forum
The Open Group Launches The Open Group Open Digital Transformation™ Forum

Yahoo

time20 minutes ago

  • Yahoo

The Open Group Launches The Open Group Open Digital Transformation™ Forum

Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Yahoo

time20 minutes ago

  • Yahoo

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store